NMDA-ANTAGONIST-PRODRUGS

Patent europeic · EP3564234 · En vigur

Inscripziun en il register

Numer da publicaziun: EP3564234
Numer da la dumonda: EP19166031
Gener: Patent europeic cun effect per la Svizra ed il Liechtenstein
Status: En vigur
Scrittira da patent: Concedì
Annunzià: 30-10-2014
Publitgà: 06-11-2019
Concedì: 29-09-2021
La protecziun finescha il pli tard: 29-10-2034
Proxima taxa annuala scadenta: 31-10-2026
Classas IPC: C07D 401/14 (2006.01)
C07D 401/12 (2006.01)
C07D 213/40 (2006.01)
A61K 31/4402 (2006.01)
A61K 31/4439 (2006.01)
A61P 25/24 (2006.01)
Prioritad: US 201361899903 P 05.11.2013
Lingua da l’annunzia: englais
Funtauna: Swissreg

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

01-11-2025
Midada
Published in Swissreg on 01.11.2025
01-11-2024
Midada
Published in Swissreg on 01.11.2024
26-01-2024
Midada
Published in Swissreg on 26.01.2024
09-01-2023
Adressa midada
Representative
ServoPatent GmbH, Wannerstrasse 9/1, 8045 Zürich → Servopatent GmbH, Bühlstrasse 1, 8125 Zollikerberg
Published in Swissreg on 09.01.2023
01-11-2022
Midada
Published in Swissreg on 01.11.2022
10-08-2022
Midada
Published in Swissreg on 10.08.2022
11-11-2021
Represchentant inscrit
Representative
ServoPatent GmbH, Wannerstrasse 9/1, 8045 Zürich
Published in Swissreg on 11.11.2021
29-09-2021
Concedì
Published in Swissreg on 29.09.2021

151 85 Södertälje, SE

Bühlstrasse 1, 8125 Zollikerberg